These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9292520

  • 1. The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.
    van Meijer M, Smilde A, Tans G, Nesheim ME, Pannekoek H, Horrevoets AJ.
    Blood; 1997 Sep 01; 90(5):1874-82. PubMed ID: 9292520
    [Abstract] [Full Text] [Related]

  • 2. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR.
    Biochemistry; 1999 Nov 02; 38(44):14592-9. PubMed ID: 10545182
    [Abstract] [Full Text] [Related]

  • 3. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA, Schapira M.
    Blood; 1994 Aug 15; 84(4):1164-72. PubMed ID: 8049432
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
    Stefansson S, Lawrence DA, Argraves WS.
    J Biol Chem; 1996 Apr 05; 271(14):8215-20. PubMed ID: 8626514
    [Abstract] [Full Text] [Related]

  • 5. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R, Umemura K, Hashimmoto H, Urano T.
    Thromb Haemost; 2006 Apr 05; 95(4):637-42. PubMed ID: 16601834
    [Abstract] [Full Text] [Related]

  • 6. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
    Ehrlich HJ, Gebbink RK, Keijer J, Linders M, Preissner KT, Pannekoek H.
    J Biol Chem; 1990 Aug 05; 265(22):13029-35. PubMed ID: 1695900
    [Abstract] [Full Text] [Related]

  • 7. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M, Stoop A, Smilde A, Preissner KT, van Zonneveld AJ, Pannekoek H.
    Thromb Haemost; 1997 Mar 05; 77(3):516-21. PubMed ID: 9066004
    [Abstract] [Full Text] [Related]

  • 8. Molecular advances in plasminogen activator inhibitor 1 interaction with thrombin and tissue-type plasminogen activator.
    Stoop A, van Meijer M, Horrevoets AJ, Pannekoek H.
    Trends Cardiovasc Med; 1997 Feb 05; 7(2):47-51. PubMed ID: 21235863
    [Abstract] [Full Text] [Related]

  • 9. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
    Keijer J, Linders M, Wegman JJ, Ehrlich HJ, Mertens K, Pannekoek H.
    Blood; 1991 Sep 01; 78(5):1254-61. PubMed ID: 1715220
    [Abstract] [Full Text] [Related]

  • 10. Additivity in effects of vitronectin and monoclonal antibodies against alpha-helix F of plasminogen activator inhibitor-1 on its reactions with target proteinases.
    Komissarov AA, Andreasen PA, Bødker JS, Declerck PJ, Anagli JY, Shore JD.
    J Biol Chem; 2005 Jan 14; 280(2):1482-9. PubMed ID: 15516335
    [Abstract] [Full Text] [Related]

  • 11. The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin.
    Urano T, Ihara H, Takada Y, Nagai N, Takada A.
    Biochim Biophys Acta; 1996 Dec 05; 1298(2):199-208. PubMed ID: 8980646
    [Abstract] [Full Text] [Related]

  • 12. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
    Arroyo De Prada N, Schroeck F, Sinner EK, Muehlenweg B, Twellmeyer J, Sperl S, Wilhelm OG, Schmitt M, Magdolen V.
    Eur J Biochem; 2002 Jan 05; 269(1):184-92. PubMed ID: 11784312
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.
    Gechtman Z, Belleli A, Lechpammer S, Shaltiel S.
    Biochem J; 1997 Jul 15; 325 ( Pt 2)(Pt 2):339-49. PubMed ID: 9230112
    [Abstract] [Full Text] [Related]

  • 15. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin.
    Ehrlich HJ, Keijer J, Preissner KT, Gebbink RK, Pannekoek H.
    Biochemistry; 1991 Jan 29; 30(4):1021-8. PubMed ID: 1703436
    [Abstract] [Full Text] [Related]

  • 16. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
    Edelberg JM, Reilly CF, Pizzo SV.
    J Biol Chem; 1991 Apr 25; 266(12):7488-93. PubMed ID: 1708387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.